Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/04/1999WO1999055868A2 Fizz proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055866A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055864A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
11/04/1999WO1999055863A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
11/04/1999WO1999055861A2 Fibroblast growth factor mutein compositions and methods of use therefor
11/04/1999WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue
11/04/1999WO1999055856A2 Nucleic acid enzyme for rna cleavage
11/04/1999WO1999055855A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055854A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055847A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
11/04/1999WO1999055843A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/04/1999WO1999055831A2 Adenoviral vectors for treating disease
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055731A1 Peptide with endotoxin-neutralizing activity
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055729A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES
11/04/1999WO1999055728A2 Ese genes and proteins
11/04/1999WO1999055726A1 Certain thiol inhibitors of endothelin-converting enzyme
11/04/1999WO1999055725A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
11/04/1999WO1999055723A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/04/1999WO1999055720A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999WO1999055669A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate
11/04/1999WO1999055564A1 Materials and methods for gene therapy
11/04/1999WO1999055382A1 Adenoviral vector encoding anti-apoptotic bcl-2 gene and uses thereof
11/04/1999WO1999055380A1 Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS
11/04/1999WO1999055378A1 Method of treating endotoxemia
11/04/1999WO1999055377A2 Polyol-ifn-beta conjugates
11/04/1999WO1999055376A1 Peg-lhrh analog conjugates
11/04/1999WO1999055370A1 Methods for reducing hiv viral load by administering gm-csf and antiretroviral agents
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999055364A2 Proteins that direct the secretion of virulence proteins and vaccines comprising them
11/04/1999WO1999055363A1 Compositions and methods for tolerization in immune complex-mediated disease progression
11/04/1999WO1999055362A1 Spray dried formulations of igf-i
11/04/1999WO1999055361A1 Neovascularization inhibitors
11/04/1999WO1999055360A1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/04/1999WO1999055359A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999WO1999055358A1 Methods for treating hot flashes and gynaecomastia
11/04/1999WO1999055357A1 Method for the treatment of fertility disorders
11/04/1999WO1999055355A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999WO1999055354A1 Fertility improving composition and application thereof
11/04/1999WO1999055353A2 Protein formulations
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055330A1 Ccr-3 receptor antagonists
11/04/1999WO1999055325A1 Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
11/04/1999WO1999055315A1 Periadventitial delivery device
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999055310A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999WO1999055309A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them
11/04/1999WO1999055306A1 Pharmaceutical composition comprising factor viii and neutral liposomes
11/04/1999WO1999055301A1 Use of horseradish peroxidase in cosmetic or dermopharmaceutical compositions for preventing and/or repairing skin damage induced by oxygen radical forms
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999046377A3 A human vanilloid receptor-like cation channel
11/04/1999WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor
11/04/1999WO1999045112A3 Chromosome 11-linked coronary heart disease susceptibility gene chd1
11/04/1999WO1999043353A3 Combination anti-selectin and immunosuppressant therapy
11/04/1999WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/04/1999WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999042473A9 Inhibition of toxin translocation
11/04/1999WO1999041984A9 INTERACTION BETWEEN THE MEC1-DEPENDENT DNA SYNTHESIS CHECKPOINT AND G1 CYCLIN FUNCTION IN $i(SACCAROMYCES CEREVISIAE)
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999037775A3 Compositions and methods for detecting and treating breast cancer
11/04/1999WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999WO1999036536A9 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/04/1999WO1999034819A3 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
11/04/1999WO1999034004A3 Metastatic breast and colon cancer regulated genes
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999029865A9 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
11/04/1999WO1999024589A3 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
11/04/1999WO1998027113A9 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
11/04/1999DE19907764A1 Preparation of acid-resistant pancreatin granulates
11/04/1999DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999DE19818938A1 A therapeutic composition for killing cancer cells and single celled infectious organisms
11/04/1999CA2565375A1 Polyol-ifn-beta conjugates
11/04/1999CA2350163A1 Identifying peptide ligands of target proteins with target complementary library technology (tclt)
11/04/1999CA2330481A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them
11/04/1999CA2330476A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999CA2330451A1 Polyol-ifn-beta conjugates
11/04/1999CA2330448A1 Peg-lhrh analog conjugates
11/04/1999CA2330033A1 Method of treating endotoxemia
11/04/1999CA2329941A1 Methods for treating hot flashes and gynaecomastia
11/04/1999CA2329929A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999CA2329920A1 Methods for reducing hiv viral load by administering gm-csf and antiretroviral agents
11/04/1999CA2329908A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999CA2329821A1 Ccr-3 receptor antagonists
11/04/1999CA2328992A1 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
11/04/1999CA2328111A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2327363A1 Process for the preparation of methyl(2s)-2-¬(3r)-3-(n-¬tert-butyloxycarbonyl|-amino)-2-oxopyrrolidin-1-yl|propionate
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999CA2327178A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999CA2326825A1 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326824A1 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326820A1 Polypeptides from moraxella (branhamella) catarrhalis
1 ... 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 ... 3163